Stockreport

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome [Yahoo! Finance]

Quoin Pharmaceuticals, Ltd. - American Depositary Shares  (QNRX) 
PDF Quoin Pharmaceuticals, Inc. — Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significa [Read more]